Human Pathology
Volume 37, Issue 3 , Pages 251-252 , March 2006

Prostate cancer diagnosis: even the experts disagree

References 

  1. Lamb DS, Denham JW, Delahunt B. Prostate cancer screening in Australasia. Clin Oncol. 2005;17:231–233
  2. Delahunt B, Nacey JN. Thin core biopsy of prostate. Pathology. 1998;30:247–256
  3. Egevad L, Allsbrook WC, Epstein JI. Current practice of diagnosis and reporting of prostate cancer on needle biopsy among genitourinary pathologists. Hum Pathol. 2006;37:292–297
  4. Biedrzycki O, Varma M, Berney DM. Variations in the processing of prostatic needle cores in the UK; what is safe?. J Clin Pathol. 2003;56:341–343
  5. Lane RB, Lane CG, Mangold KA, et al. Needle biopsies of the prostate: what constitutes adequate histologic sampling?. Arch Pathol Lab Med. 1998;122:833–835
  6. Renshaw AA. Adequate tissue sampling for prostate needle core biopsies. Am J Clin Pathol. 1997;107:26–29
  7. Brat DJ, Willis ML, Lecksell KL, et al. How often are diagnostic features missed with less extensive histological sampling of prostate needle biopsy specimens?. Am J Surg Pathol. 1999;23:257–262
  8. Epstein JI, Yang XJ. Needle biopsy technique, tissue sampling, and processing of needle biopsies and transurethral resection specimen. Chapter 2 In: Prostate biopsy interpretation. 3rd ed.. Philadelphia: Lippincott, Williams, & Wilkins; 2002;p. 7–10
  9. Wojno KJ, Epstein JI. The utility of basal cell-specific anti-cytokeratin antibody (34beta E12) in the diagnosis of prostate carcinoma. A review of 228 cases. Am J Surg Pathol. 1995;19:251–260
  10. Totten RS, Heinemann MW, Hudson PB, Sproul EE, Stout AP. Microscopic differential diagnosis of latent carcinoma of prostate. Arch Pathol. 1953;55:131–141
  11. Cheville JC, Reznicek MJ, Bostwick DG. The focus of atypical glands suspicious for malignancy in prostatic needle biopsy specimens: incidence, histologic features and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol. 1997;108:633–640
  12. Reyes AO, Humphrey PA. Diagnostic effect of complete histologic sampling of prostate needle biopsy specimens. Am J Clin Pathol. 1998;109:416–422
  13. Algaba F, Epstein JI, Aldape HC, et al. Assessment of prostate cancer in core needle biopsy—definition of minimal criteria for the diagnosis of cancer in biopsy material. Cancer. 1996;78:376–381
  14. Epstein JI. Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy. Mod Pathol. 2004;17:307–315
  15. Pacelli A, Lopez-Beltran A, Egan AJM, Bostwick DG. Prostatic adenocarcinoma with glomeruloid features. Hum Pathol. 1998;28:543–546
  16. McNeal JE, Alroy J, Villers A, et al. Mucinous differentiation in prostatic adenocarcinoma. Hum Pathol. 1991;22:979–988
  17. Bostwick DG, Wollan P, Adlakha K. Collagenous micronodules in prostate cancer. A specific but infrequent diagnostic finding. Arch Pathol Lab Med. 1995;119:444–447
  18. Varma M, Lee MW, Tamboli P, et al. Morphologic criteria for the diagnosis of prostatic adenocarcinoma in needle biopsy specimens. A study of 250 consecutive cases in a routine surgical pathology practice. Arch Pathol Lab Med. 2002;126:554–561
  19. Humphrey PA. Adenocarcinoma. Chapter 14 In: Prostate pathology. Chicago: American Society for Clinical Pathology; 2003;p. 258–337

PII: S0046-8177(06)00024-4

doi: 10.1016/j.humpath.2006.01.004

Human Pathology
Volume 37, Issue 3 , Pages 251-252 , March 2006

Article Tools